Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host

Jan M. Boitz, Phillip Yates, Chelsey Kline, Upasna Gaur, Mary E. Wilson, Buddy Ullman, Sigrid C. Roberts

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Mutations within the polyamine biosynthetic pathway of Leishmania donovani, the etiological agent of visceral leishmaniasis, confer polyamine auxotrophy to the insect vector or promastigote form of the parasite. However, whether the infectious or amastigote form of the parasite requires an intact polyamine pathway has remained an open question. To address this issue, conditionally lethal δodc mutants lacking ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, were created by double targeted gene replacement within a virulent strain of L. donovani. ODC-deficient promastigotes and axenic amastigotes were auxotrophic for polyamines and capable of robust growth only when exogenous putrescine was supplied in the culture medium, confirming that polyamine biosynthesis is an essential nutritional pathway for L. donovani promastigotes. To assess whether the δodc lesion also affected the ability of amastigotes to sustain a robust infection, macrophage and mouse infectivity experiments were performed. Parasite loads in murine macrophages infected with each of two independent δodc knockout lines were decreased ∼S0% compared to their wild-type counterpart. Furthermore, α-difluoromethylornithine, a suicide inhibitor of ODC., inhibited growth of wild-type L. donovani amastigotes and effectively cured macrophages of parasites, thereby preventing host cell destruction. Strikingly, however, parasitemias of both δodc null mutants were reduced by 6 and 3 orders of magnitude, respectively, in livers and spleens of BALB/c mice. The compromised infectivity pheno-types of the δodc knockouts in both macrophages and mice were rescued by episomal complementation of the genetic lesion. These genetic and pharmacological studies strongly implicate ODC as an essential cellular determinant that is necessary for the viability and growth of both L. donovani promastigotes and amastigotes and intimate that pharmacological inhibition of ODC is a promising therapeutic paradigm for the treatment of visceral and perhaps other forms of leishmaniasis.

Original languageEnglish (US)
Pages (from-to)756-763
Number of pages8
JournalInfection and Immunity
Volume77
Issue number2
DOIs
StatePublished - Feb 2009

Fingerprint

Leishmania donovani
Ornithine Decarboxylase
Polyamines
Parasites
Macrophages
Growth
Pharmacology
Insect Vectors
Parasite Load
Eflornithine
Aptitude
Leishmaniasis
Putrescine
Visceral Leishmaniasis
Parasitemia
Biosynthetic Pathways
Suicide
Culture Media
Spleen
Mutation

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Parasitology
  • Infectious Diseases

Cite this

Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host. / Boitz, Jan M.; Yates, Phillip; Kline, Chelsey; Gaur, Upasna; Wilson, Mary E.; Ullman, Buddy; Roberts, Sigrid C.

In: Infection and Immunity, Vol. 77, No. 2, 02.2009, p. 756-763.

Research output: Contribution to journalArticle

Boitz, Jan M. ; Yates, Phillip ; Kline, Chelsey ; Gaur, Upasna ; Wilson, Mary E. ; Ullman, Buddy ; Roberts, Sigrid C. / Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host. In: Infection and Immunity. 2009 ; Vol. 77, No. 2. pp. 756-763.
@article{8e3fee3ca2fc468f989f4b564c50ed69,
title = "Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host",
abstract = "Mutations within the polyamine biosynthetic pathway of Leishmania donovani, the etiological agent of visceral leishmaniasis, confer polyamine auxotrophy to the insect vector or promastigote form of the parasite. However, whether the infectious or amastigote form of the parasite requires an intact polyamine pathway has remained an open question. To address this issue, conditionally lethal δodc mutants lacking ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, were created by double targeted gene replacement within a virulent strain of L. donovani. ODC-deficient promastigotes and axenic amastigotes were auxotrophic for polyamines and capable of robust growth only when exogenous putrescine was supplied in the culture medium, confirming that polyamine biosynthesis is an essential nutritional pathway for L. donovani promastigotes. To assess whether the δodc lesion also affected the ability of amastigotes to sustain a robust infection, macrophage and mouse infectivity experiments were performed. Parasite loads in murine macrophages infected with each of two independent δodc knockout lines were decreased ∼S0{\%} compared to their wild-type counterpart. Furthermore, α-difluoromethylornithine, a suicide inhibitor of ODC., inhibited growth of wild-type L. donovani amastigotes and effectively cured macrophages of parasites, thereby preventing host cell destruction. Strikingly, however, parasitemias of both δodc null mutants were reduced by 6 and 3 orders of magnitude, respectively, in livers and spleens of BALB/c mice. The compromised infectivity pheno-types of the δodc knockouts in both macrophages and mice were rescued by episomal complementation of the genetic lesion. These genetic and pharmacological studies strongly implicate ODC as an essential cellular determinant that is necessary for the viability and growth of both L. donovani promastigotes and amastigotes and intimate that pharmacological inhibition of ODC is a promising therapeutic paradigm for the treatment of visceral and perhaps other forms of leishmaniasis.",
author = "Boitz, {Jan M.} and Phillip Yates and Chelsey Kline and Upasna Gaur and Wilson, {Mary E.} and Buddy Ullman and Roberts, {Sigrid C.}",
year = "2009",
month = "2",
doi = "10.1128/IAI.01236-08",
language = "English (US)",
volume = "77",
pages = "756--763",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host

AU - Boitz, Jan M.

AU - Yates, Phillip

AU - Kline, Chelsey

AU - Gaur, Upasna

AU - Wilson, Mary E.

AU - Ullman, Buddy

AU - Roberts, Sigrid C.

PY - 2009/2

Y1 - 2009/2

N2 - Mutations within the polyamine biosynthetic pathway of Leishmania donovani, the etiological agent of visceral leishmaniasis, confer polyamine auxotrophy to the insect vector or promastigote form of the parasite. However, whether the infectious or amastigote form of the parasite requires an intact polyamine pathway has remained an open question. To address this issue, conditionally lethal δodc mutants lacking ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, were created by double targeted gene replacement within a virulent strain of L. donovani. ODC-deficient promastigotes and axenic amastigotes were auxotrophic for polyamines and capable of robust growth only when exogenous putrescine was supplied in the culture medium, confirming that polyamine biosynthesis is an essential nutritional pathway for L. donovani promastigotes. To assess whether the δodc lesion also affected the ability of amastigotes to sustain a robust infection, macrophage and mouse infectivity experiments were performed. Parasite loads in murine macrophages infected with each of two independent δodc knockout lines were decreased ∼S0% compared to their wild-type counterpart. Furthermore, α-difluoromethylornithine, a suicide inhibitor of ODC., inhibited growth of wild-type L. donovani amastigotes and effectively cured macrophages of parasites, thereby preventing host cell destruction. Strikingly, however, parasitemias of both δodc null mutants were reduced by 6 and 3 orders of magnitude, respectively, in livers and spleens of BALB/c mice. The compromised infectivity pheno-types of the δodc knockouts in both macrophages and mice were rescued by episomal complementation of the genetic lesion. These genetic and pharmacological studies strongly implicate ODC as an essential cellular determinant that is necessary for the viability and growth of both L. donovani promastigotes and amastigotes and intimate that pharmacological inhibition of ODC is a promising therapeutic paradigm for the treatment of visceral and perhaps other forms of leishmaniasis.

AB - Mutations within the polyamine biosynthetic pathway of Leishmania donovani, the etiological agent of visceral leishmaniasis, confer polyamine auxotrophy to the insect vector or promastigote form of the parasite. However, whether the infectious or amastigote form of the parasite requires an intact polyamine pathway has remained an open question. To address this issue, conditionally lethal δodc mutants lacking ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, were created by double targeted gene replacement within a virulent strain of L. donovani. ODC-deficient promastigotes and axenic amastigotes were auxotrophic for polyamines and capable of robust growth only when exogenous putrescine was supplied in the culture medium, confirming that polyamine biosynthesis is an essential nutritional pathway for L. donovani promastigotes. To assess whether the δodc lesion also affected the ability of amastigotes to sustain a robust infection, macrophage and mouse infectivity experiments were performed. Parasite loads in murine macrophages infected with each of two independent δodc knockout lines were decreased ∼S0% compared to their wild-type counterpart. Furthermore, α-difluoromethylornithine, a suicide inhibitor of ODC., inhibited growth of wild-type L. donovani amastigotes and effectively cured macrophages of parasites, thereby preventing host cell destruction. Strikingly, however, parasitemias of both δodc null mutants were reduced by 6 and 3 orders of magnitude, respectively, in livers and spleens of BALB/c mice. The compromised infectivity pheno-types of the δodc knockouts in both macrophages and mice were rescued by episomal complementation of the genetic lesion. These genetic and pharmacological studies strongly implicate ODC as an essential cellular determinant that is necessary for the viability and growth of both L. donovani promastigotes and amastigotes and intimate that pharmacological inhibition of ODC is a promising therapeutic paradigm for the treatment of visceral and perhaps other forms of leishmaniasis.

UR - http://www.scopus.com/inward/record.url?scp=60549113705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549113705&partnerID=8YFLogxK

U2 - 10.1128/IAI.01236-08

DO - 10.1128/IAI.01236-08

M3 - Article

C2 - 19064633

AN - SCOPUS:60549113705

VL - 77

SP - 756

EP - 763

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 2

ER -